Evidence map›Paper›PMID 31601985›Full record

ArticleScientific reports2019

Raman Spectroscopy for Rapid Evaluation of Surgical Margins during Breast Cancer Lumpectomy.

Willie C Zúñiga, Veronica Jones, Sarah M Anderson, Alex Echevarria, Nathaniel L Miller, Connor Stashko, Daniel Schmolze, Philip D Cha, Ragini Kothari, Yuman Fong and 1 more

Abstract readEvaluation Study
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Scientific Advances in Cancer Detection Using Raman Spectroscopy.Asian Pacific journal of cancer prevention : APJCP · 2024
    Review
  15. Article
  16. Current clinical applications of Cerenkov luminescence for intraoperative molecular imaging.European journal of nuclear medicine and molecular imaging · 2024
    Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Willie C ZúñigaHarvey Mudd College, Department of Physics, 301 Platt Blvd., Claremont, CA, 91711, USA.
Veronica JonesHarvey Mudd College, Department of Engineering, 301 Platt Blvd., Claremont, CA, 91711, USA. vjones@coh.org.
Sarah M AndersonHarvey Mudd College, Department of Engineering, 301 Platt Blvd., Claremont, CA, 91711, USA.
Alex EchevarriaHarvey Mudd College, Department of Physics, 301 Platt Blvd., Claremont, CA, 91711, USA.
Nathaniel L MillerHarvey Mudd College, Department of Engineering, 301 Platt Blvd., Claremont, CA, 91711, USA.
Connor StashkoHarvey Mudd College, Department of Engineering, 301 Platt Blvd., Claremont, CA, 91711, USA.
Daniel SchmolzeCity of Hope National Medical Center, Department of Surgery, 1500 E. Duarte Rd, Duarte, CA, 91010, USA.
Philip D ChaHarvey Mudd College, Department of Engineering, 301 Platt Blvd., Claremont, CA, 91711, USA.
Ragini KothariCity of Hope National Medical Center, Department of Surgery, 1500 E. Duarte Rd, Duarte, CA, 91010, USA.
Yuman FongCity of Hope National Medical Center, Department of Surgery, 1500 E. Duarte Rd, Duarte, CA, 91010, USA.
Michael C Storrie-LombardiHarvey Mudd College, Department of Physics, 301 Platt Blvd., Claremont, CA, 91711, USA.

Funding

Transgenic Mouse FacilityP30CA033572 · NCI · CITY OF HOPE/BECKMAN RESEARCH INSTITUTE · PI Victoria L. Seewaldt · 1985 to 2026
$86.3M
NCI NIH HHS P30 CA033572
6 · The paper itself

Abstract

Failure to precisely distinguish malignant from healthy tissue has severe implications for breast cancer surgical outcomes. Clinical prognoses depend on precisely distinguishing healthy from malignant tissue during surgery. Laser Raman spectroscopy (LRS) has been previously shown to differentiate benign from malignant tissue in real time. However, the cost, assembly effort, and technical expertise needed for construction and implementation of the technique have prohibited widespread adoption. Recently, Raman spectrometers have been developed for non-medical uses and have become commercially available and affordable. Here we demonstrate that this current generation of Raman spectrometers can readily identify cancer in breast surgical specimens. We evaluated two commercially available, portable, near-infrared Raman systems operating at excitation wavelengths of either 785 nm or 1064 nm, collecting a total of 164 Raman spectra from cancerous, benign, and transitional regions of resected breast tissue from six patients undergoing mastectomy. The spectra were classified using standard multivariate statistical techniques. We identified a minimal set of spectral bands sufficient to reliably distinguish between healthy and malignant tissue using either the 1064 nm or 785 nm system. Our results indicate that current generation Raman spectrometers can be used as a rapid diagnostic technique distinguishing benign from malignant tissue during surgery.

Indexed as

Margins of ExcisionMastectomy, SegmentalBreastBreast NeoplasmsFemaleHumansIntraoperative CarePrincipal Component AnalysisSpectroscopy, Near-InfraredSpectrum Analysis, RamanTime Factors

Identifiers

PMID31601985
PMCPMC6787043

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.